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Abstract
Metronidazole is an antibiotic and used for the treatment of the diseases caused by the anaerobic bacteria and protozoa. 
The aim of this research work was to estimate the impact of the Trivedi Effect®-Consciousness Energy Healing Treatment on 
the physicochemical, thermal behavior of metronidazole using modern analytical techniques. The test sample metronidazole 
was divided into two parts. One part of the sample did not receive the Biofield Energy Treatment and called as a control sample. 
While the other part was received the Consciousness Energy Healing Treatment remotely by a well-known Biofield Energy 
Healer, Gopal Nayak and termed as a treated sample. The particle size values in the treated metronidazole powder sample were 
significantly decreased by 25.47% (d10), 12.96% (d50), 11.16% (d90), and 13.49% {D (4,3)}; thus, the specific surface area was 
significantly increased by 33.21% compared to the control sample. The powder XRD peak intensities and crystallite sizes of 
the treated powder sample were significantly altered ranging from -43.4% to 396.77% and -67.47% to 187.56%, respectively; 
whereas, the average crystallite size was significantly decreased by 13.16% compared with the control sample. The latent heat of 
fusion and latent heat of decomposition were significantly increased by 14.44% and 23.39%, respectively in the treated sample 
compared with the control sample. The weight loss was decreased by 1.49%; hence the residue amount was significantly increased 
by 65.2% in the treated sample compared with the control sample. The maximum thermal degradation temperature was increased 
by 3.04% in the treated sample compared to the control sample. The Trivedi Effect®-Consciousness Energy Healing Treatment 
might have generated a new polymorphic form of metronidazole which may offer better solubility, dissolution rate, absorption, 
bioavailability, therapeutic efficacy, and thermal stability compared with the control sample. The Consciousness Energy Healing 
Treated metronidazole sample would be more efficacious pharmaceutical formulations for the treatment of the infections in the 
vagina, stomach, liver, skin, joints, brain, and respiratory tract, aspiration pneumonia, fungating wounds, rosacea, amoebiasis, 
periodontitis, etc.
.
Keywords: Complementary and Alternative Medicine; 
Consciousness Energy Healing Treatment; Metronidazole; Particle 
size; Surface area; The Trivedi Effect®; PXRD, DSC, TGA/DTG
Introduction
Metronidazole is an antibiotic and antiprotozoal medication. 
It is also used against the diseases caused by the anaerobic bacteria. It 
works selectively blocking the nucleic acid synthesis by disrupting 
the DNA of microbial cells and the parasites resulting in their death 
[1,2]. It is used to treat bacterial vaginosis, pseudomembranous 
colitis, giardiasis, pelvic inflammatory disease, abscess of the 
ovaries and fallopian tubes, infections in brain, and respiratory 
tract, aspiration pneumonia, rosacea, intra-abdominal infections, 
fungating wounds, lung abscess, periodontitis, amoebiasis, 
oral infections, and the infections caused by the Bacteroides, 
Clostridium, Helicobacter pylori, Fusobacterium, Dracunculus, 
Peptostreptococcus, and Prevotella species, etc. [2-5]. 
It is also used to treat Giardia in domestic animals [2,6]. 
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Some of the side effects of associated with metronidazole therapy 
are nausea, vomiting, hypersensitivity reactions, stomatitis, 
dark urine, neutropenia, vaginal dryness, peripheral neuropathy, 
decrease of libido, central nervous system toxicity, paraesthesia 
etc. [2,7]. The metronidazole is delivered in the form of liquid 
suspension (metronidazole benzoate), capsule, tablet, and 
intravenous injection [7-8]. It is hazardous when con on the 
contact of skin, eye, inhalation, and ingestion. It is slightly soluble 
in water, other organic solvents (alcohol, chloroform, dilute acid, 
and dimethylformamide) [9,10].
The physicochemical properties of the pharmaceutical 
or nutraceutical compounds play a crucial role in stability, 
dissolution, and bioavailability profile in the human body [11]. In 
this concern, the Trivedi Effect®-Consciousness Energy Healing 
Treatment worldwide recognized as a wonderful and scientifically 
proved phenomenon altered the physicochemical properties 
such as crystallite size, particle size, thermal properties, and 
bioavailability of the pharmaceutical and nutraceutical compounds 
[12-15]. The Trivedi Effect® is a natural and only scientifically 
proven phenomenon in which an expert can harness this inherently 
intelligent energy from the universe and transmit it anywhere in the 
world through the possible mediation of neutrinos [16]. A unique 
infinite and para-dimensional electromagnetic field energy field 
exists around the body of every living being called the “Biofield”. 
The Biofield based Energy Healing Therapies have been reported 
significant benefit against various disease conditions [16,17]. 
The National Institutes of Health (NIH) and the National 
Center for Complementary and Alternative Medicine (NCCAM) 
approved and included the Energy therapy under Complementary 
and Alternative Medicine (CAM) category, which has been 
accepted by the most of the U.S. population [18,19]. Likewise, 
the Trivedi Effect®-Consciousness Energy Healing Treatment 
also has huge potential to alter the physicochemical, structural, 
and behavioural properties of metals, polymers, ceramics, and 
organic compounds, microorganisms, cancer cells [20-28], and 
improve the overall productivity of crops [29,30]. The current 
study was designed to evaluate the impact of the Trivedi Effect®-
Consciousness Energy Healing Treatment on the physicochemical 
and thermal properties of metronidazole powder using Particle Size 
Analysis (PSA), Powder X-Ray Diffraction (PXRD), Differential 
Scanning Calorimetry (DSC), and Thermogravimetric Analysis/
Differential Thermogravimetric Analysis (TGA/DTG).
Materials and Methods 
Chemicals and Reagents
Metronidazole was purchased from Tokyo Chemical Industry 
Co., Ltd., Japan and the other chemicals were of analytical grade 
purchased in India.
Consciousness Energy Healing Treatment Strategies
The metronidazole taken as a test sample was further divided 
into two equal parts. One part of the test sample was treated with 
the Consciousness Energy Healing Treatment (the Trivedi Effect®) 
remotely under standard laboratory conditions for 3 minutes by the 
renowned Biofield Energy Healer, Gopal Nayak, India, and known 
as Biofield Energy Treated sample. However, the other part of the 
test sample did not receive the Biofield Energy Treatment and was 
termed as a control sample. Further, the control sample was treated 
with a “sham” healer, who did not have any knowledge about the 
Biofield Energy Treatment. Both the samples were kept in sealed 
conditions for the characterization using PSA, PXRD, DSC, and 
TGA analytical techniques.
Characterization
The PSA was performed using Malvern Mastersizer 2000 
(UK) using the wet method [31,32]. The PXRD analysis of 
metronidazole powder sample was performed with the help of 
Rigaku MiniFlex-II Desktop X-ray diffractometer (Japan) [33,34]. 
The average size of crystallites was calculated from PXRD data 
using the Scherrer’s formula (1)
G = kλ/βcosθ  (1)
Where G is the crystallite size in nm, k is the equipment 
constant, λ is the radiation wavelength, β is the full-width at half 
maximum, and θ is the Bragg angle [35]. 
Similarly, the DSC analysis of metronidazole was performed 
with the help of DSC Q200, TA instruments.  The TGA/DTG 
thermograms of metronidazole were obtained with the help of 
TGA Q50 TA instruments [31,32]. 
The % change in particle size, specific surface area, peak 
intensity, crystallite size, latent heat, melting point, weight loss 
and the maximum thermal degradation temperature of the Biofield 
Energy Treated metronidazole was calculated compared with the 
control sample using the following equation 2:
     (2)
Results and Discussion
Particle Size Analysis (PSA)
The particle size values of the control metronidazole powder 
sample at d10, d50, d90, and D (4,3) were 143.91 µm, 291.19 µm, 
523.2 µm, and 313.69 µm, respectively. Similarly, the particle 
sizes of the Biofield Energy Treated metronidazole powder sample 
at d10, d50, d90, and D (4,3) were 107.25 µm, 253.45 µm, 464.8 
µm, and 271.36 µm, respectively. The particle size values at d10, 
d50, d90, and D (4,3) in the Biofield Energy Treated metronidazole 
powder sample were significantly decreased by 25.47%, 12.96%, 
11.16%, and 13.49%, respectively compared to the control sample. 
Thus, the Specific Surface Area (SSA) of the treated metronidazole 
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powder (0.0357 m2/g) was significantly increased by 33.21% compared to the control sample (0.0268 m2/g).  It can be presumed that 
after the Trivedi Effect®-Consciousness Energy Healing Treatment the larger particles fractured to smaller particles of metronidazole, 
hence increased the surface area. Thus, it can be expected that the Biofield Energy Treated metronidazole sample might offer better 
solubility, dissolution rate, absorption, bioavailability, and therapeutic efficacy compared to the control sample [36,37].
Parameter d10 (µm) d50 (µm) d90 (µm) D(4,3) (µm) SSA (m2/g)
Control 143.91 291.19 523.20 313.69 0.0268
Biofield Energy Treated 107.25 253.45 464.80 271.36 0.0357
Percent change (%) -25.47 -12.96 -11.16 -13.49 33.21
d10, d50, and d90: particle diameter corresponding to 10%, 50%, and 90% of the cumulative distribution, D (4,3): the average mass-volume diameter, 
and SSA: the specific surface area.
Table 1: Particle size distribution of the control and Biofield Energy Treated metronidazole powder sample.
Powder X-Ray Diffraction (PXRD) Analysis 
The PXRD diffractograms of both the samples showed sharp and intense peaks (Figure 1) indicated that both the samples were 
crystalline. The diffractograms of the control and Biofield Energy Treated metronidazole powder samples showed the highest peak 
intensity at 2θ equal to 12.54° and 12.72° (Table 2, entry 1). The peak intensities of the Biofield Energy Treated sample was significantly 
altered ranging from -43.4% to 396.77% compared to the control sample (Table 2). Similarly, the crystallite sizes of the Biofield Energy 
Treated metronidazole was significantly altered ranging from -67.47% to 187.56% compared with the control sample. Overall, the 
crystallite sizes of the Biofield Energy Treated metronidazole powder sample were significantly altered in the range from -63.08% to 
344.35% compared to the control sample. However, the average crystallite size of the Biofield Energy Treated powder sample (333.57 
nm) was significantly decreased by 13.16% compared to the control sample (384.14 nm).
Figure 1:  Powder XRD diffractograms of the control and Biofield Energy Treated metronidazole powder sample.
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Entry No.
Bragg angle (°2θ) Peak Intensity (%) Crystallite size (G, nm)
Control Treated Control Treated % Change Control Treated % Change
1 12.54 12.72 1499.00 6830.00 355.64 283.00 336.00 18.73
2 13.85 14.18 295.00 1133.00 284.07 608.00 467.00 -23.19
3 17.40 17.54 212.00 120.00 -43.40 486.00 233.00 -52.06
4 18.24 18.36 163.00 350.00 114.72 794.00 334.00 -57.93
5 19.41 19.59 34.00 40.00 17.65 164.00 146.00 -10.98
6 21.77 21.85 110.00 182.00 65.45 959.00 312.00 -67.47
7 23.39 23.66 31.00 154.00 396.77 225.00 647.00 187.56
8 24.62 24.88 230.00 198.00 -13.91 355.00 294.00 -17.18
9 25.34 25.77 335.00 306.00 -8.66 263.00 256.00 -2.66
10 27.34 27.70 528.00 347.00 -34.28 537.00 234.00 -56.42
11 29.47 29.61 530.00 404.00 -23.77 312.00 531.00 70.19
12 33.38 33.53 276.00 559.00 102.54 156.00 435.00 178.85
13 43.80 43.59 157.00 128.00 -18.47 125.00 277.00 121.60
14 46.49 46.80 97.00 112.00 15.46 111.00 168.00 51.35
15 Average crystallite size 384.14 333.57 -13.16
Table 2: PXRD data for the control and Biofield Energy Treated metronidazole powder sample.
The alteration in the peak intensities and crystallite sizes indicated the change in the crystal morphology and production of new 
polymorph [38-40] of the treated metronidazole powder compared to the control sample. The Trivedi Effect®-Consciousness Energy 
Healing Treatment probably accountable for the production of the new polymorphic form of metronidazole via the possible mediation of 
neutrino oscillations [16]. Altered polymorphic forms of pharmaceutical compounds have the significant effects on the drug performance, 
such as bioavailability, therapeutic efficacy, and toxicity, because of their different thermodynamic and physicochemical properties from 
the original one [41]. Hence, the Biofield Energy Treated metronidazole would be better in designing more efficacious pharmaceutical 
formulation
Differential Scanning Calorimetry (DSC) Analysis
The thermograms of the control metronidazole samples showed the sharp endothermic and exothermic peak at 160.87°C and 
286.43°C, respectively (Figure 2). Likewise, the control metronidazole samples showed the sharp endothermic and exothermic peak at 
161.68°C and 287.83°C, respectively (Figure 2). The experimental data were very close to the literature reported data [9]. The melting 
point and decomposition temperature of the treated metronidazole were increased by 0.5% and 0.49%, respectively compared to the 
control sample (Table 3). The latent heat of fusion (∆Hfusion) and latent heat of decomposition (∆Hdecomposition) of the treated metronidazole 
were significantly increased by 14.44% and 23.39%, respectively compared to the control sample (Table 3). Any change in the latent heat 
of fusion can be attributed to the disrupted molecular chains and the crystal structure [42,43]. Thus, the Trivedi Effect®-Consciousness 
Energy Healing Treatment might have improved the molecular chains strength of the Biofield Energy Treated metronidazole molecule 
so that the thermal stability of the treated sample was increased compared with the control sample.
Sample Melting Temp (°C) Decomposition Temp (°C) ∆H (J/g)Fusion Decomposition
Control Sample 160.87 286.43 183.50 1056.00
Biofield Energy Treated 161.68 287.83 210.00 1303.00
% Change 0.50 0.49 14.44 23.39
ΔH: Latent heat of fusion/decomposition.
Table 3: DSC data for both control and Biofield Energy Treated samples of metronidazole powder sample.
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Figure 2. DSC thermograms of the control and Biofield Energy Treated metronidazole powder sample.
Thermal Gravimetric Analysis (TGA) / Differential Thermogravimetric Analysis (DTG)
Both the metronidazole samples showed one step of thermal degradation in the TGA thermograms (Figure 3). The total weight loss 
of the treated metronidazole was decreased by 1.49% more compared to the control sample (Table 4). However, the residue amount was 
significantly increased by 65.2% in the Biofield Energy Treated metronidazole compared to the control sample (Table 4).
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Figure 3: TGA thermograms of the control and Biofield Energy Treated metronidazole powder sample.
Sample
TGA DTG
Total weight loss (%) Residue (%) Tmax (°C)
Control 97.77 2.23 233.96
Biofield Energy Treated 96.316 3.684 241.08
% Change* -1.49 65.20 3.04
*denotes the percentage change of the Biofield Energy Treated sample with respect to the control sample, T
max
 = the temperature at which 
maximum weight loss takes place in TG or peak temperature in DTG.
Table 4: TGA/DTG data of the control and Biofield Energy Treated samples of metronidazole powder sample.
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Figure 4: DTG thermograms of the control and Biofield Energy Treated 
metronidazole powder sample.
The DTG thermograms of both the samples showed one 
peak in the thermograms (Figure 4); where, the maximum thermal 
degradation temperature (T
max
) of the Biofield Energy Treated 
metronidazole was increased by 3.04% compared to the control 
sample (Table 4). The overall thermal analysis of metronidazole 
powder samples revealed that the thermal stability of the Trivedi 
Effect®-Biofield Energy Treated sample was increased compared 
to the control sample.
Conclusions
The experimental results showed that the Trivedi Effect®-
Consciousness Energy Healing Treatment has a significant effect 
on the thermal, and behavioral properties of metronidazole. The 
particle size values in the Biofield Energy Treated metronidazole 
powder sample were significantly decreased by 25.47% (d10), 
12.96% (d50), 11.16% (d90), and 13.49% {D (4,3)}; thus, the 
specific surface area was significantly increased by 33.21% 
compared to the control sample. The powder XRD peak intensities 
and crystallite sizes of the Biofield Energy Treated powder sample 
were significantly altered ranging from -43.4% to 396.77% and 
-67.47% to 187.56%, respectively; whereas, the average crystallite 
size was significantly decreased by 13.16% compared with the 
control sample. The ∆Hfusion and ∆Hdecomposition were significantly 
increased by 14.44% and 23.39%, respectively in the Biofield 
Energy Treated sample compared with the control sample. The 
total weight loss was decreased by 1.49%; hence the residue 
amount was significantly increased by 65.2% in the Biofield 
Energy Treated sample compared with the control sample. 
The T
max
 was increased by 3.04% in the Biofield Energy 
Treated sample compared with the control sample. The Trivedi 
Effect®-Consciousness Energy Healing Treatment might have 
generated a new polymorphic form of metronidazole which 
may offer better solubility, bioavailability, therapeutic efficacy, 
and thermal stability compared with the control sample. The 
Consciousness Energy Healing Treated metronidazole sample 
would be more efficacious pharmaceutical formulations for the 
treatment of bacterial vaginosis, pseudomembranous colitis, 
giardiasis, pelvic inflammatory disease, abscess of the ovaries and 
fallopian tubes, infections in brain, and respiratory tract, aspiration 
pneumonia, rosacea, intra-abdominal infections, fungating wounds, 
lung abscess, periodontitis, amoebiasis, oral infections, and the 
infections caused by the Bacteroides, Clostridium, Helicobacter 
pylori, Fusobacterium, Dracunculus, Peptostreptococcus, and 
Prevotella species, etc.
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